Literature DB >> 23987003

[Meta analysis of the relationship between human papilloma virus and nasal inverted papilloma].

Wu Xiao1, Shanfeng Liu, Liyin Wang, Huimin Li, Wenwei Wu, Zhenhai Wang.   

Abstract

OBJECTIVE: To evaluate the relationship between human papilloma virus (HPV) infection and the occurrence, recurrence and malignant transformation of nasal inverted papilloma (NIP).
METHOD: With comprehensive retrieval of related literature that had been published in databases included Pubmed (1990--2011), Cochrane Library, CNKI (1979-2011), VIP (1989-2011), CBM (1990-2011) and WANFANG Meta-analysis software Rev-Man 5.0 was used to analyze the raw data and to calculate the value of combined odd ratio (OR) and 95% confidence interval (CI). RESULT: According to Meta-analysis, the occurrence group between HPV and NIP, the OR was 34.44 and 95% CI was 12.96-91.56; the recurrence group, the OR was 3.66 and 95% CI was 1.77-7.56, to the high-risk HPV, the OR was 1.94 and 95% CI was 0.30-12.58; the malignant transformation group, the OR was 1.79 and 95% CI was 0.94-3.40 to the high-risk HPV, the OR was 49.35 and 95% (CI was 0.45-11.23.
CONCLUSION: HPV may play an important role in the occurrence and recurrence of NIP and high-risk HPV was closely related to the progress of NIP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23987003

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  2 in total

1.  Prevalence of Human Papilloma Virus in Sinonasal Papilloma in Southern Iranian Population.

Authors:  Behnaz Valibeigi; Mohamad Javad Ashraf; Narges Kerdegari; Akbar Safai; Elham Abedi; Bijan Khademi; Negar Azarpira
Journal:  J Dent (Shiraz)       Date:  2017-06

2.  Distribution of 37 human papillomavirus types in parotid gland tumor tissues.

Authors:  Wei-Qiang Teng; Xiao-Ping Chen; Xiao-Cheng Xue; Yi Zhang; Xue-Jun Tan; Guangbin Sun; Yan Wang; Li Wang
Journal:  Oncol Lett       Date:  2013-12-23       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.